A custom virtual reality training solution for ophthalmologic surgical clinical trials
Felix Heimann, Giulio Barteselli, André Brand, Andreas Dingeldey, Laszlo Godard, Hendrik Hochstetter, Michael Schneider, Alexander Rothkegel, Clemens Wagner, Joshua Horvath, Shrirang Ranade, Felix Heimann, Giulio Barteselli, André Brand, Andreas Dingeldey, Laszlo Godard, Hendrik Hochstetter, Michael Schneider, Alexander Rothkegel, Clemens Wagner, Joshua Horvath, Shrirang Ranade
Abstract
We present a summary of the development and clinical use of two custom designed high-fidelity virtual-reality simulator training platforms. This simulator development program began in 2016 to support the phase III clinical trial Archway (ClinicalTrials.gov identifier, NCT03677934) intended to evaluate the Port Delivery System (PDS) developed by Genentech Inc. and has also been used to support additional clinical trials. The two simulators address two specific ophthalmic surgical procedures required for the successful use of PDS and provide state-of-the-art physical simulation models and graphics. The simulators incorporate customized active haptic feedback input devices that approximate different hand pieces including a custom hand piece specifically designed for PDS implantation. We further describe the specific challenges of the procedure and the development of corresponding training strategies realized within the simulation platform.
Conflict of interest statement
The custom simulator development described was a collaborative effort of Genentech Inc. and VRmagic GmbH. All authors are employees of either VRmagic GmbH or Genentech Inc.
Figures
References
- Prescient & Strategic Intelligence: Section 5.1 - By Offering . Surgical Simulation Market Research Report, LS11131. 2020. pp. 55–60.
- Campochiaro PA, Marcus DM, Awh CC, Regillo C, Adamis AP, Bantseev V, et al. The port delivery system with ranibizumab for neovascular age-related macular degeneration: results from the randomized phase 2 ladder clinical trial. Ophthalmology. 2019;126(8):1141–54. 10.1016/j.ophtha.2019.03.036.
- Panteleimon P, Chorti A, Papagiouvanni I, Paparoidamis G, Drosos C, Panagiotakopoulos T, et al. Virtual and augmented reality in medical education. Intechopen. 2018. 10.5772/intechopen.71963.
- Rangarajan K, Davis H, Pucher PH. Systematic review of virtual haptics in surgical simulation: a valid educational tool? J Surg Educ. 2020;77(2):337–347. doi: 10.1016/j.jsurg.2019.09.006.
- Bantseev V, Schuetz C, Booler HS, Horvath J, Hovaten K, Erickson S, Bentley E, Nork TM, Freeman WR, Stewart JM, Barteselli G. Evaluation of surgical factors affecting vitreous hemorrhage following Port Delivery System with ranibizumab implant insertion in a minipig model. Retina. 2020;40(8):1520–1528. doi: 10.1097/IAE.0000000000002614.
- Spraul CW, Grossniklaus HE. Vitreous hemorrhage. Surv Ophthalmol. 1997;42(1):3–39. 10.1016/s0039-6257(97)84041-6.
- Lee R, Raison N, Lau WY, Aydin A, Dasgupta P, Ahmed K, Haldar S. A systematic review of simulation-based training tools for technical and non-technical skills in ophthalmology. Eye. 2020;34(10):1737–1759. doi: 10.1038/s41433-020-0832-1.
- Norman RE, Flanagan JG, Rausch SMK, Sigal IA, Tertinegg I, Eilaghi A, et al. Dimensions of the human sclera: thickness measurement and regional changes with axial length. Exp Eye Res. 2010;90(2):277–84. 10.1016/j.exer.2009.11.001.
- Castellanos S. Genentech uses virtual reality to train eye surgeons. The Wall Street Journal, February 6th 2019. .
- Pieramici DJ, Heimann F, Brassard R, Barteselli G, Ranade S. Virtual reality becomes a reality for ophthalmologic surgical clinical trials. Trans Vis Sci Tech. 2020;9–7:1.
Source: PubMed